How Did CARE Ratings Perform in FY25?
CARE Ratings Limited, India’s second-largest credit rating agency, reported its strongest financial performance to date for the fiscal year ended March 31, 2025. According to the company’s audited results, CARE Ratings delivered all-time high revenue and profitability figures across both standalone and consolidated operations, driven by robust momentum in ratings assignments and a growing share of advisory and analytics contributions.
Standalone revenue from operations grew by 19% year-on-year to ₹336.7 crore, while consolidated revenue rose 21% to ₹402.3 crore. On profitability metrics, the company’s standalone EBITDA surged by 22% to ₹155.2 crore, maintaining a high margin of 46%. Standalone PAT increased 24% to ₹147.9 crore, with a 38% PAT margin, reinforcing the firm’s operating efficiency. On a consolidated basis, EBITDA rose 39% to ₹155.3 crore and PAT jumped 37% to ₹140.0 crore, reflecting significant margin expansion.
For the March quarter (Q4 FY25), standalone and consolidated income from operations both posted a 22% increase year-on-year. Notably, consolidated PAT surged 77% to ₹43.4 crore in Q4, highlighting substantial profitability improvements in overseas and non-ratings segments.
What Is Driving CARE Ratings’ Growth?
CARE Ratings attributed its strong performance to increased traction in its core ratings business, particularly in initial ratings of capital market instruments, securitisation transactions, and bank debt assessments. Segmentally, the ratings business accounted for 89.5% of consolidated revenue in FY25, posting a 21% year-on-year rise to ₹360.1 crore. The remaining 10.5% came from non-ratings businesses, which grew 27% to ₹42.2 crore.
Its diversified growth strategy also gained traction across geographies. Subsidiaries such as CARE Ratings (Africa), CARE Ratings South Africa, CARE Ratings Nepal, and CareEdge Global IFSC Ltd. contributed meaningfully to the consolidated performance, especially through new sovereign ratings and global debt evaluations. CareEdge Global, for instance, assigned global scale ratings to debt instruments worth approximately USD 3 billion across 39 countries.
How Are Advisory and ESG Segments Contributing?
The company’s non-ratings businesses, including its analytics, advisory, and sustainability offerings, are becoming stronger contributors. CARE ESG Ratings Ltd. executed six ESG ratings in FY25, following SEBI approval as a Category I ESG Ratings provider under the issuer-pays model.
Meanwhile, CARE Analytics and Advisory Private Ltd. expanded its consulting footprint by delivering bespoke financial appraisals, policy reviews, and ESG strategy consulting. It also launched EdgeAvira.AI, an AI-driven analytics platform, positioning itself at the convergence of credit intelligence and fintech innovation.
What Is the Broader Economic Context for FY25?
FY25 saw a moderation in India’s GDP growth to 6.5% from 9.2% the previous year, as per the Second Advance Estimate. Sluggish global trade, softening external demand, and subdued public capex weighed on economic momentum. Gross fixed capital formation growth fell to 6.1% from 8.8% in FY24, although private consumption revived on the back of improving rural demand.
Financial markets saw renewed fundraising activity. Corporate bond issuances grew 6% to ₹11.0 lakh crore, while commercial paper issuances rose sharply by 14.5% to ₹15.7 lakh crore. These trends supported the addressable market for CARE Ratings, enabling higher assignment volumes and fee-based revenue.
Bank credit growth, however, moderated to 10.1% year-on-year as of March 2025, compared to 16.7% a year earlier. The slowdown in credit to services was largely due to higher risk weights for NBFCs, though regulatory normalisation may aid a rebound in FY26.
What Are the Key Performance Metrics for FY25?
CARE Ratings achieved robust profitability with industry-leading margins. On a standalone basis, EBITDA margin stood at 46%, while PAT margin came in at 38%. Consolidated EBITDA margin improved from 34% in FY24 to 39% in FY25, and consolidated PAT margin expanded from 27% to 31%.
The company’s earnings per share (EPS) grew significantly. Standalone EPS rose to ₹49.49 from ₹39.89 a year ago, while consolidated EPS stood at ₹45.89, indicating enhanced shareholder returns.
Additionally, the Board recommended a final dividend of ₹11 per share (₹10 face value), taking the full-year dividend to ₹18 per share, signalling strong cash flows and capital return philosophy.
What Is the Investor and Analyst Sentiment Around CARE Ratings Stock?
CARE Ratings stock (NSE: CARE, BSE: 534804) has seen renewed investor interest following its FY25 results. The significant earnings beat, strong margin expansion, and consistent dividend payouts are positively influencing institutional sentiment. Market observers note that the company’s asset-light model, growing diversification, and high return ratios make it an attractive mid-cap play in the Indian financial services sector.
FII and DII activity post-results has shown an uptick in cumulative buying, according to early exchange data, with particular inflows into ETFs and long-only funds focused on the India midcap financial theme. Analysts tracking the company believe CARE Ratings’ scalable ratings platform, combined with growth in ESG and analytics, positions it well in a post-reform regulatory environment.
Sentiment remains bullish, with multiple brokerages upgrading their target prices in light of the consolidated PAT growth and guidance stability. However, some market participants have flagged potential downside risks if credit growth does not rebound sharply in FY26 or if regulatory norms on issuer-paid ratings evolve unexpectedly.
What Is the Forward Outlook for CARE Ratings?
CARE Ratings appears well-positioned to sustain growth momentum in FY26 despite macroeconomic headwinds. GDP is forecast to moderate slightly to 6.2%, but supportive tailwinds such as softening inflation, the prospect of a normal monsoon, and lower interest rates could aid demand for credit ratings and advisory services.
The company’s strategic investments in ESG, international ratings, and AI-driven analytics are likely to yield long-term dividends. Additionally, with the government budgeting a 10.1% rise in capital expenditure to ₹11.2 trillion in FY26, infrastructure-linked rating activity is expected to remain buoyant.
The diversification into global sovereign ratings, ESG evaluation, and advanced risk analytics provides a hedge against domestic market cyclicality. Management reiterated its commitment to operational efficiency and quality-led expansion, which could continue to drive margins.
Looking ahead, investors will be closely watching CARE Ratings’ ability to deepen its market share amid intensifying competition, while also scaling newer business verticals profitably.
Discover more from Business-News-Today.com
Subscribe to get the latest posts sent to your email.
